Literature DB >> 30116654

Towards superior dendritic-cell vaccines for cancer therapy.

Mansi Saxena1, Sreekumar Balan1, Vladimir Roudko1, Nina Bhardwaj2,3.   

Abstract

Entities:  

Year:  2018        PMID： 30116654      PMCID： PMC6089533          DOI： 10.1038/s41551-018-0250-x

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN： 2157-846X            Impact factor:   25.671


× No keyword cloud information.
  52 in total

1.  Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma.

Authors:  Sofie Wilgenhof; Jurgen Corthals; Carlo Heirman; Nicolas van Baren; Sophie Lucas; Pia Kvistborg; Kris Thielemans; Bart Neyns
Journal:  J Clin Oncol       Date:  2016-02-29       Impact factor: 44.544

2.  siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells.

Authors:  Willemijn Hobo; Frans Maas; Niken Adisty; Theo de Witte; Nicolaas Schaap; Robbert van der Voort; Harry Dolstra
Journal:  Blood       Date:  2010-08-03       Impact factor: 22.113

Review 3.  Langerhans Cells - The Macrophage in Dendritic Cell Clothing.

Authors:  Thomas Doebel; Benjamin Voisin; Keisuke Nagao
Journal:  Trends Immunol       Date:  2017-07-15       Impact factor: 16.687

Review 4.  Trial watch: Dendritic cell-based anticancer immunotherapy.

Authors:  Abhishek D Garg; Monica Vara Perez; Marco Schaaf; Patrizia Agostinis; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-05-12       Impact factor: 8.110

5.  Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1.

Authors:  Evelyn Hartung; Martina Becker; Annabell Bachem; Nele Reeg; Anika Jäkel; Andreas Hutloff; Harald Weber; Christoph Weise; Claudia Giesecke; Volker Henn; Stephanie Gurka; Konstantinos Anastassiadis; Hans W Mages; Richard A Kroczek
Journal:  J Immunol       Date:  2014-12-17       Impact factor: 5.422

Review 6.  Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients.

Authors:  Sreekumar Balan; John Finnigan; Nina Bhardwaj
Journal:  Cancer J       Date:  2017 Mar/Apr       Impact factor: 3.360

7.  A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer.

Authors:  Rebecca L Prue; Frank Vari; Kristen J Radford; Hui Tong; Melinda Y Hardy; Rachael D'Rozario; Nigel J Waterhouse; Tony Rossetti; Robert Coleman; Christopher Tracey; Hans Goossen; Vinay Gounder; Georgina Crosbie; Sonia Hancock; Stephanie Diaz-Guilas; Paul Mainwaring; Peter Swindle; Derek N J Hart
Journal:  J Immunother       Date:  2015 Feb-Mar       Impact factor: 4.456

Review 8.  Dendritic-cell-based therapeutic cancer vaccines.

Authors:  Karolina Palucka; Jacques Banchereau
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

9.  Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors.

Authors:  Alexandra-Chloé Villani; Rahul Satija; Gary Reynolds; Siranush Sarkizova; Karthik Shekhar; James Fletcher; Morgane Griesbeck; Andrew Butler; Shiwei Zheng; Suzan Lazo; Laura Jardine; David Dixon; Emily Stephenson; Emil Nilsson; Ida Grundberg; David McDonald; Andrew Filby; Weibo Li; Philip L De Jager; Orit Rozenblatt-Rosen; Andrew A Lane; Muzlifah Haniffa; Aviv Regev; Nir Hacohen
Journal:  Science       Date:  2017-04-21       Impact factor: 47.728

Review 10.  Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies.

Authors:  Renske J E van den Bijgaart; Dylan C Eikelenboom; Martijn Hoogenboom; Jurgen J Fütterer; Martijn H den Brok; Gosse J Adema
Journal:  Cancer Immunol Immunother       Date:  2016-09-01       Impact factor: 6.968
View more
  29 in total

Review 1.  Antitumour dendritic cell vaccination in a priming and boosting approach.

Authors:  Alexandre Harari; Michele Graciotti; Michal Bassani-Sternberg; Lana E Kandalaft
Journal:  Nat Rev Drug Discov       Date:  2020-08-06       Impact factor: 84.694

Review 2.  Metabolism and immunity in breast cancer.

Authors:  Deyu Zhang; Xiaojie Xu; Qinong Ye
Journal:  Front Med       Date:  2020-10-19       Impact factor: 4.592

3.  Generation of Tumor Targeted Dendritic Cell Vaccines with Improved Immunogenic and Migratory Phenotype.

Authors:  Adam M Swartz; Kelly M Hotchkiss; Smita K Nair; John H Sampson; Kristen A Batich
Journal:  Methods Mol Biol       Date:  2022

4.  Immune activation of the monocyte-derived dendritic cells using patients own circulating tumor cells.

Authors:  Katarina Kolostova; Eliska Pospisilova; Rafal Matkowski; Jolanta Szelachowska; Vladimir Bobek
Journal:  Cancer Immunol Immunother       Date:  2022-04-26       Impact factor: 6.630

5.  Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8+ T Cell Responses with Antitumor Activity.

Authors:  Matthew G Booty; Kelan A Hlavaty; Adam Stockmann; Emrah Ilker Ozay; Carolyne Smith; Lina Tian; Edylle How; Disha Subramanya; Anita Venkitaraman; Christian Yee; Olivia Pryor; Kelly Volk; Katarina Blagovic; Ildefonso Vicente-Suarez; Defne Yarar; Melissa Myint; Amy Merino; Jonathan Chow; Tarek Abdeljawad; Harry An; Sophia Liu; Shirley Mao; Megan Heimann; LeeAnn Talarico; Miye K Jacques; Eritza Chong; Lucas Pomerance; John T Gonzalez; Ulrich H von Andrian; Klavs F Jensen; Robert Langer; Hendrik Knoetgen; Christine Trumpfheller; Pablo Umaña; Howard Bernstein; Armon Sharei; Scott M Loughhead
Journal:  J Immunol       Date:  2022-01-28       Impact factor: 5.426

Review 6.  Cancer immunotherapies revisited: state of the art of conventional treatments and next-generation nanomedicines.

Authors:  Coral García-Fernández; Anna Saz; Cristina Fornaguera; Salvador Borrós
Journal:  Cancer Gene Ther       Date:  2021-04-09       Impact factor: 5.987

7.  Cryomicroneedles for transdermal cell delivery.

Authors:  Hao Chang; Sharon W T Chew; Mengjia Zheng; Daniel Chin Shiuan Lio; Christian Wiraja; Yu Mei; Xiaoyu Ning; Mingyue Cui; Aung Than; Peng Shi; Dongan Wang; Kanyi Pu; Peng Chen; Haiyan Liu; Chenjie Xu
Journal:  Nat Biomed Eng       Date:  2021-05-03       Impact factor: 25.671

8.  Fecal microbiota composition associates with the capacity of human peripheral blood monocytes to differentiate into immunogenic dendritic cells in vitro.

Authors:  Dušan Radojević; Sergej Tomić; Dušan Mihajlović; Maja Tolinački; Bojan Pavlović; Dragana Vučević; Svetlana Bojić; Nataša Golić; Miodrag Čolić; Jelena Đokić
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 9.  Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications.

Authors:  Annalisa Del Prete; Francesca Sozio; Ilaria Barbazza; Valentina Salvi; Laura Tiberio; Mattia Laffranchi; Angela Gismondi; Daniela Bosisio; Tiziana Schioppa; Silvano Sozzani
Journal:  Int J Mol Sci       Date:  2020-05-30       Impact factor: 5.923

10.  In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.

Authors:  Takaaki Oba; Kenichi Makino; Ryutaro Kajihara; Toshihiro Yokoi; Ryoko Araki; Masumi Abe; Hans Minderman; Alfred E Chang; Kunle Odunsi; Fumito Ito
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.